Literature DB >> 1926068

Intraduodenal absorption of the new UF-heparin salt ITF 1057 in the conscious dog.

I Caramazza1, G D'Atri, M L Bossi, F De Ponti, L D'Angelo, A Crema.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1926068     DOI： 10.1016/0049-3848(91)90383-8

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  4 in total

1.  Oral delivery of new heparin derivatives in rats.

Authors:  Y Lee; S H Kim; Y Byun
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

2.  Influence of formulation factors on tablet formulations with liquid permeation enhancer using factorial design.

Authors:  Naveen K Bejugam; Helen J Parish; Gita N Shankar
Journal:  AAPS PharmSciTech       Date:  2009-12-01       Impact factor: 3.246

3.  Antiangiogenic activity of orally absorbable heparin derivative in different types of cancer cells.

Authors:  Dong Yun Lee; Sung Won Lee; Sang Kyoon Kim; Myungjin Lee; Hyo Won Chang; Hyun Tae Moon; Youngro Byun; Sang Yoon Kim
Journal:  Pharm Res       Date:  2009-10-15       Impact factor: 4.200

4.  Papain: an effective permeation enhancer for orally administered low molecular weight heparin.

Authors:  Vjera Grabovac; Thierry Schmitz; Florian Föger; Andreas Bernkop-Schnürch
Journal:  Pharm Res       Date:  2007-03-20       Impact factor: 4.580
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.